Table 3 Overall survival time by stratification factor

From: Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Median survival time (months)

   

(95% CI)

GC ( N =41)

GEM ( N =42)

P -value

Tumour site

 Gallbladder

9.1 (6.9, 11.6)

6.7 (4.2, 11.0)

0.675

 Non-gallbladder

13.0 (9.2, ***)

8.0 (6.1, 16.0)

0.110

Primary tumour

 Presence of primary tumour

9.4 (8.7, 11.6)

7.4 (5.9, 8.5)

0.253

 Absence of primary tumour

16.1 (12.3, ***)

12.7 (6.5, ***)

0.389

  1. Abbreviations: GC=gemcitabine and cisplatin; GEM=gemcitabine; CI=confidence interval.
  2. ***denotes upper limits are not available.
Back to article page